
TRADING DAY Good vibrations turn sour
ORLANDO, Florida, June 11 (Reuters) - TRADING DAY
Making sense of the forces driving global markets
By Jamie McGeever, Markets Columnist
I'm excited to announce that I'm now part of Reuters Open Interest (ROI), an essential new source for data-driven, expert commentary on market and economic trends. You can find ROI on the Reuters website, and you can follow us on LinkedIn and X.
The US and China have reached a trade deal, or at least agreed on the framework of a deal, which together with surprisingly soft U.S. inflation data, gave markets a lift on Wednesday. But Wall Street's gains were mild, and they were later wiped out by rising tensions in the Middle East.
In my column today I look at the 'equity risk premium' and other metrics that suggest relative U.S. equity and bond valuations are getting very stretched. More on that below, but first, a roundup of the main market moves.
If you have more time to read, here are a few articles I recommend to help you make sense of what happened in markets today.
Today's Key Market Moves
Good vibrations turn sour
It's a "done" deal, according to U.S. President Donald Trump, although the he and Chinese leader Xi Jinping still have to finalize the wording of the trade agreement between the two superpowers and sign off on it.
The main points of the deal appear to be: China will remove export restrictions on rare earth minerals and other key industrial components; U.S. tariffs on Chinese goods will total 55%; Chinese tariffs on U.S. goods will total 10%.
Trump could not have been more enthusiastic in his praise for the agreement on Wednesday, and Commerce Secretary Howard Lutnick said 'deal after deal' with other countries will follow in the weeks ahead.
Yet, judging by the relatively muted market reaction, investors are less enthused. And given the chaotic and unpredictable nature of the Trump administration's tariff announcements thus far, the irony of Treasury Secretary Scott Bessent calling on China to be a "reliable partner" in trade negotiations will not be lost on some observers. Especially, one suspects, in Beijing.
Based on these proposed China levies, and with the US expected to conclude more trade deals in the coming weeks, the overall U.S. effective tariff rate will be lower than feared a couple of months ago. That's a relief.
But the effective tariff rate of around 15% that many economists expect will still be significantly higher than the 2.5% rate at the end of last year, and would be the highest since the 1930s. Also, as the May inflation figures showed, tariffs have yet to be felt on prices.
Investors - and Fed policymakers, who meet next week - are in a state of limbo. How will corporate profits and consumer spending be affected? What proportion of the tariffs will companies "swallow", and how much will they pass on to their customers?
Zooming out, inflation appears to be cooling around the world, although this trend is expected to reverse once tariffs start to fuel higher goods price inflation.
Figures on Wednesday showed that U.S. consumer inflation and Japanese wholesale inflation were lower than expected in May. These reports follow similar numbers from Europe recently, and China remains stuck in its battle against deflation.
Next up is India, which releases consumer inflation figures on Thursday, which are expected to show annual inflation slowed to 3.0% in May, the lowest in more than six years. Another focus for investors on Thursday will be the auction of 30-year U.S. Treasury bonds.
US stocks-bonds warnings flash amber again
Calm has descended on U.S. markets following the 'Liberation Day' tariff turmoil of early April. But Wall Street's rally has revived questions about U.S. equity valuations, as stocks once again look super pricey compared to bonds.
Since the chaotic days of early April, U.S. equities have rebounded fiercely, with the S&P 500 up 25%, putting the Shiller cyclically adjusted price-earnings (CAPE) ratio for the index in the 94th percentile going back to the 1950s, according to bond giant PIMCO.
Stocks are looking expensive in absolute terms, and in relation to bonds. The equity risk premium (ERP), the difference between equity yields and bond yields, is near historically low levels.
According to analysts at PIMCO, the ERP is now zero. The previous two times it fell to zero or below were in 1987 and 1996–2001. In both instances, the ultra-low ERP precipitated a steep equity drawdown and sharp fall in long-dated bond yields.
"The U.S. equity risk premium ... is exceptionally low by historical standards," they wrote in their five-year outlook on Tuesday. "A mean reversion to a higher equity risk premium typically involves a bond rally, an equity sell-off, or both."
But reversion to the mean doesn't just happen by magic. A catalyst is needed. Equities have recovered largely because they were oversold in April, trade tensions have been dialed down, and investors remain confident that Big Tech will drive solid AI-led earnings growth.
So even though huge economic, trade, and policy risks continue to hang over markets, there is no sign of an imminent catalyst that would cause an equity market selloff.
The flip side of equities looking expensive is that bonds look like a bargain.
Indeed, the relative divergence between stocks and bonds is such that, by one measure, U.S. fixed income assets are the cheapest relative to equities in over half a century.
Using national flow of funds data from the Federal Reserve, retired strategist Jim Paulsen calculates that the total market value of U.S. bonds as a percentage share of the total market value of U.S. equities is the lowest since the early 1970s.
"Since the aggregate U.S. portfolio is currently aggressively positioned, investors may have far more capacity and desire to boost bond holdings in the coming years than most appreciate," Paulsen wrote last week.
But bonds are 'cheap' for a reason. Washington's profligacy – the reason ratings agency Moody's recently stripped the U.S. of its triple-A credit rating – and inflation worries have kept yields stubbornly high. The term premium - the risk premium investors demand for holding long-term debt rather than rolling over short-dated loans - is the highest in over a decade, reflecting concerns about Uncle Sam's long-term fiscal health.
And the diagnosis here shows no signs of improving. Trump's 'Big Beautiful Bill' is expected to add $2.4 trillion to the U.S. debt over the next decade, according to the nonpartisan Congressional Budget Office, likely putting more upward pressure on yields.
Of course, equity investors do seem to be pricing in a very rosy scenario, and the past few months have shown how quickly the market landscape can change. The U.S. economy could weaken more than expected, the trade war could escalate, or there could be a geopolitical surprise that causes bond yields and equity prices to fall.
Investors should therefore be mindful of the warnings being sent by ERPs and other absolute and relative valuation metrics. However, they should also remember that stretched valuations can get even more stretched. As the famous saying goes, markets can stay irrational longer than investors can remain solvent.
What could move markets tomorrow?
Opinions expressed are those of the author. They do not reflect the views of Reuters News, which, under the Trust Principles, opens new tab, is committed to integrity, independence, and freedom from bias.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Reuters
an hour ago
- Reuters
Short-seller Chanos questions bitcoin-holding pioneer Strategy's valuation premium
June 12 (Reuters) - Prominent short-seller Jim Chanos has questioned Strategy's (MSTR.O), opens new tab valuation premium over its bitcoin holdings, saying Chairman Michael Saylor's tactics to boost the company's returns are "financial gibberish." "...Mr. Saylor wants you to value his business based not only on the net value of his Bitcoin holdings (NAV) at market, but additionally with a multiple on the change in that NAV...," he said in a post on X on Tuesday. Also, in an interview with Bloomberg Television on Wednesday, Chanos said that Strategy's market value should not exceed the value of its bitcoin holdings. As of June 9, the company held 582,000 bitcoins, worth $62.27 billion, while its market value of $108 billion was about 1.74 times its crypto holdings. Chanos and other Strategy critics have argued that this disconnect was creating an arbitrage opportunity for buying the cryptocurrency and shorting the firm's shares. Strategy did not immediately respond to a Reuters request for comment. Following Strategy's footsteps, companies like GameStop (GME.N), opens new tab and U.S. President Donald Trump's Trump Media & Technology (DJT.O), opens new tab have also pivoted their operations to building bitcoin reserves. Strategy's shares are up nearly 34% this year, eclipsing bitcoin's 14.2% climb. Saylor has argued that critics overlook his company's innovative use of bitcoin-backed financial instruments, which he insists justify the premium at which the company trades and protect it from the risks Chanos highlights. The company actively issues bitcoin-backed credit instruments, such as non-cumulative preferred stock, allowing it to raise capital without diluting common shareholders or taking on traditional debt obligations.


Reuters
an hour ago
- Reuters
One Cycling project not included in next season's UCI calendar
June 12 (Reuters) - The UCI opted not to include the One Cycling project when it launched its World Tour and Women's World Tour calendars for 2026 on Thursday, with the governing body saying it was incompatible with its regulatory framework. The project, reportedly backed by an investment firm owned by Saudi Arabia's Public Investment Fund (PIF), aims to revolutionise cycling with the support of major teams and race organisers. One Cycling wanted an overhaul of the calendar and the possible creation of new competitions to generate new sources of revenue. "The project, which had been developed by certain teams and organisers in collaboration with a sports investment fund, was deemed incompatible with the governance and regulatory framework of the UCI as well as lacking sporting coherence," a UCI press release said. The UCI said it welcomed the fact that cycling is attracting new investors and wished to continue discussions with the project's representatives. There is one addition to the women's calendar with the Dwars door Vlaanderen on April 1, after the race had previously been run on the UCI ProSeries calendar, the second-tier tour. In an effort to promote the continued development of women's cycling, the UCI Management Committee approved a 20% increase in the participation allowance paid by organisers of Women's World Tour events to participating teams.


Reuters
an hour ago
- Reuters
Kenvue mulls sale of some skin health and beauty brands, sources say
NEW YORK, June 12 (Reuters) - Kenvue (KVUE.N), opens new tab is exploring the sale of some of its skin health and beauty brands, four people familiar with the matter said on Thursday, as the consumer health firm prunes an underperforming business segment to focus on core products. The company, which was spun out of Johnson & Johnson (JNJ.N), opens new tab in 2023, is zeroing in on smaller brands in the unit to sell such as Clean & Clear, Maui Moisture, Neostrata, its German baby care brand Bebe, and Japanese brand the sources said. It plans to hold onto the bigger names in the unit, such as Neutrogena and Aveeno, the sources said. There are about a dozen brands in the skin health and beauty unit, and sources cautioned that the divestiture package could change and no deal was guaranteed. Investment bankers at Goldman Sachs (GS.N), opens new tab are working with Kenvue on the divestment process, they added. Kenvue and Goldman declined to comment. The around half-dozen brands earmarked for sale would generate more than $500 million of revenue together, two of the sources said, a small portion of Kenvue's overall revenue, which was $15.5 billion in 2024. The skin health and beauty unit has been a drag on Kenvue's earnings, but the company has dedicated more money to marketing, especially on Neutrogena ad campaigns. The unit's organic sales declined 4.8% year-over-year in Kenvue's latest quarter that ended March 30. Kenvue, which also makes Tylenol and Band-Aids, has faced activist pressure over the last year from Starboard Value, Toms Capital Management and Third Point. It settled with Starboard in March, when it added the investment firm's founder to its board. Some of the activists have been pushing the company to consider selling itself or certain brands. In May, the company brought on new Chief Financial Officer Amit Banati from Kellanova(K.N), opens new tab , Kellogg's spun-out snacking unit.